Literature DB >> 525206

Glycosylated hemoglobin concentrations in patients with diabetic neuropathy.

V J McCann, R E Davis.   

Abstract

Glycosylated hemoglobin (Hb) concentrations were measured in 50 patients with clinically significant diabetic neuropathy. There were 24 males and 26 females with a mean age of 58.1 years and a mean duration of diabetes of 8.9 years. The glycosylated Hb concentration was not significantly different in these patients (13.9% +/- 2.4 SD) compared with randomly selected diabetic patients matched for age (+/- 5 years), sex and therapy without clinical evidence of neuropathy (13.6% +/- 2.2). There was no significant difference in the duration of diabetes between the two groups. The results would suggest that factors other than the degree of control of diabetes are important in the pathogenesis of diabetic neuropathy.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 525206     DOI: 10.1007/BF02629113

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  10 in total

1.  DIABETIC NEUROPATHY: A METABOLIC OR A VASCULAR DISEASE?

Authors:  J PIRART
Journal:  Diabetes       Date:  1965-01       Impact factor: 9.461

2.  Diabetic neuropathy: a consideration of factors in onset.

Authors:  M ELLENBERG
Journal:  Ann Intern Med       Date:  1960-05       Impact factor: 25.391

3.  Hemoglobin AIc as an indicator of the degree of glucose intolerance in diabetes.

Authors:  R J Koenig; C M Peterson; C Kilo; A Cerami; J R Williamson
Journal:  Diabetes       Date:  1976-03       Impact factor: 9.461

4.  Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus.

Authors:  R J Koenig; C M Peterson; R L Jones; C Saudek; M Lehrman; A Cerami
Journal:  N Engl J Med       Date:  1976-08-19       Impact factor: 91.245

5.  Hemoglobin components in patients with diabetes mellitus.

Authors:  L A Trivelli; H M Ranney; H T Lai
Journal:  N Engl J Med       Date:  1971-02-18       Impact factor: 91.245

6.  Rapid estimation (2 1/2 hours) of glycosylated haemoglobin for routine purposes.

Authors:  P A Kynoch; H Lehmann
Journal:  Lancet       Date:  1977-07-02       Impact factor: 79.321

7.  Diabetic neuropathy: influence of age, sex, metabolic control, and duration of diabetes on motor conduction velocity.

Authors:  G Gregersen
Journal:  Neurology       Date:  1967-10       Impact factor: 9.910

8.  The neuropathies associated with diabetes mellitus. A clinical and electromyographic study of 103 unselected diabetic patients.

Authors:  D W MULDER; E H LAMBERT; J A BASTRON; R G SPRAGUE
Journal:  Neurology       Date:  1961-04       Impact factor: 9.910

9.  Glycosylated haemoglobin levels in patients with diabetes mellitus.

Authors:  R E Davis; D J Nicol; V J McCann; J S Calder
Journal:  Med J Aust       Date:  1978-05-20       Impact factor: 7.738

10.  Glycosylated hemoglobins and long-term blood glucose control in diabetes mellitus.

Authors:  K H Gabbay; K Hasty; J L Breslow; R C Ellison; H F Bunn; P M Gallop
Journal:  J Clin Endocrinol Metab       Date:  1977-05       Impact factor: 5.958

  10 in total
  3 in total

1.  Elevated glycosylated hemoglobin in diabetic neuropathy.

Authors:  A J Boulton; C A Hardisty; R C Worth; J Drury; J D Ward
Journal:  Acta Diabetol Lat       Date:  1982 Oct-Dec

2.  Peripheral nerve function in relation to quality of metabolic control in diabetes.

Authors:  F W Bertelsmann; J J Heimans; J C van Rooy; C Popp-Snijders; E A van der Veen
Journal:  J Neurol       Date:  1987-06       Impact factor: 4.849

3.  Acetylator status and diabetic neuropathy.

Authors:  G M Shenfield; V J McCann; R Tjokresetio
Journal:  Diabetologia       Date:  1982-06       Impact factor: 10.122

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.